Search for Clinical Trial Results

Sponsored By

Ichthyosis - 33 Studies Found

Status Study
Completed Study Name: Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy
Condition: Soft Tissue Sarcoma, Adult, Stage II
Date: 2017-04-17
Interventions: Drug: Apatinib Apatinib 500 mg is administered orally daily, until disease progression or untolerable to
NOT_YET_RECRUITING Study Name: Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)
Condition: Autosomal Recessive Ichthyosis
Date: 2025-09-05
Interventions: Replication-defective, non-integrating HSV-1 vector expressing TGM1 formulated as a topical gel
COMPLETED Study Name: An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses
Condition: Ichthyosis
Date: 2025-09-05
Interventions: Each subject will receive ustekinumab at Baseline (Day 0) and Months 1, 3, 5, 7, 9, and 11.During the LTE, subjects will receive injections ever
<<< Previous